Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation (2018)
Fonte: Revista de saude publica. Unidade: FM
Assuntos: SOBREVIDA, NEOPLASIAS OVARIANAS, MUTAÇÃO GENÉTICA, GENES SUPRESSORES DE TUMOR, CUSTOS DOS CUIDADOS DE SAÚDE
ABNT
RAMOS, Marcelo Cristiano de Azevedo et al. Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation. Revista de saude publica, v. 52, 2018Tradução . . Disponível em: https://doi.org/10.11606/S1518-8787.2018052000643. Acesso em: 30 set. 2024.APA
Ramos, M. C. de A., Folgueira, M. A. A. K., Maistro, S., Campolina, A. G., Soarez, P. C. de, Bock, G. H. de, et al. (2018). Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation. Revista de saude publica, 52. doi:10.11606/S1518-8787.2018052000643NLM
Ramos MC de A, Folgueira MAAK, Maistro S, Campolina AG, Soarez PC de, Bock GH de, Novaes HMD, Diz MDPE. Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation [Internet]. Revista de saude publica. 2018 ; 52[citado 2024 set. 30 ] Available from: https://doi.org/10.11606/S1518-8787.2018052000643Vancouver
Ramos MC de A, Folgueira MAAK, Maistro S, Campolina AG, Soarez PC de, Bock GH de, Novaes HMD, Diz MDPE. Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation [Internet]. Revista de saude publica. 2018 ; 52[citado 2024 set. 30 ] Available from: https://doi.org/10.11606/S1518-8787.2018052000643